Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems

Ramana, Lakshmi Narashimhan and Sharma, Shilpee and Sethuraman, Swaminathan and Ranga, Udaykumar and Krishnan, Uma Maheswari (2014) Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems. In: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1840 (1). pp. 476-484.

PDF bio_et_bio_act_gen_sub_1840_1_476_2014.pdf - Published Version Restricted to Registered users only Download (934kB) | Request a copy

Abstract

Background: Antiretroviral Therapy (ART) is currently the major therapeutic intervention in the treatment of AIDS. ART, however, is severely limited due to poor availability, high cytotoxicity, and enhanced metabolism and clearance of the drug molecules by the renal system. The use of nanocarriers encapsulating the antiretroviral drugs may provide a solution to the aforementioned problems. Importantly, the application of mildly immunogenic polymeric carrier confers the advantage of making the nanoparticles more visible to the immune system leading to their efficient uptake by the phagocytes. Methods: The saquinavir-loaded chitosan nanopartides were characterized by transmission electron microscopy and differential scanning calorimetry and analyzed for the encapsulation efficiency, swelling characteristics, particle size properties, and the zeta potential. Furthermore, cellular uptake of the chitosan nanocarriers was evaluated using confocal microscopy and Flow cytometry. The antiviral efficacy was quantified using viral infection of the target cells. Results: Using novel chitosan carriers loaded with saquinavir, a protease inhibitor, we demonstrate a drug encapsulation efficiency of 75% and cell targeting efficiency greater than 92%. As compared to the soluble drug control, the saquinavir-loaded chitosan carriers caused superior control of the viral proliferation as measured by using two different viral strains, NL4-3 and Indie-C1, and two different target T-cells, Jurkat and CEM-CCR5. Conclusion: Chitosan nanoparticles loaded with saquinavir were characterized and they demonstrated superior drug loading potential with greater cell targeting efficiency leading to efficient control of the viral proliferation in target T-cells. General significance: Our data ascertain the potential of chitosan nanocarriers as novel vehicles for HIV-1 therapeutics. (C) 2013 Elsevier B.V. All rights reserved.

Item Type:	Journal Article
Publication:	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Publisher:	ELSEVIER SCIENCE BV
Additional Information:	Copyright for this article belongs to the ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
Keywords:	Nanocarrier; Chitosan; Saquinavir; Antiretroviral
Department/Centre:	Division of Biological Sciences > Molecular Biophysics Unit
Date Deposited:	11 Mar 2014 06:39
Last Modified:	11 Mar 2014 06:39
URI:	http://eprints.iisc.ac.in/id/eprint/48554

Actions (login required)

View Item